The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-017-3161-0
Published Online: 2017-10-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nassereddine, Samah
Lap, Coen J.
Haroun, Faysal
Tabbara, Imad
License valid from 2017-10-31